Plenary Programme

Sunday 06 May 09:00-11:00

RISK FACTORS AND PREDICTORS FOR CARDIOVASCULAR DISEASE

Chair:
  • Lale Tokgozoglu, Turkey
  • Alberto Mello e Silva, Portugal
Lessons from epidemiology and environmental CVD risk factors
Salim Yusuf, Hamilton, Canada
Is there need to revise goals for lipid lowering?
Ulf Landmesser, Berlin, Germany
Imaging and CVD risk estimation (population studies)
Valentin Fuster, New York, USA
Stress, behavior and cardiovascular disease
Viola Vaccarino, Atlanta, USA

Sunday 06 May 13:00-13:30

KEYNOTE LECTURE BY PROFESSOR PETER LIBBY

Chair:
  • Christoph Binder, Austria
  • Petri Kovanen, Finland
Anti-inflammatory therapy and resolution of inflammation, theory and practice
Peter Libby, Boston/Paris, USA/France

Monday 07 May 09:00-11:00

PATHOGENESIS OF ATHEROSCLEROSIS

Chair:
  • Jan Borén, Sweden
  • Arnold von Eckardstein, Switzerland
Neoatherosclerosis from a pathologist's point of view
Renu Virmani, Gaithersburg, USA
RNA editing controls atherosclerosis
Stefanie Dimmeler, Frankfurt, Germany
Defective inflammatory resolution in atherosclerosis: Mechanisms and therapeutic opportunities
Ira Tabas, New York, USA
Shifting concepts in the description of the "vulnerable plaque"
Gerard Pasterkamp, Utrecht, The Netherlands

Monday 07 May 13:00-13:30

KEYNOTE LECTURE BY PROFESSOR MARJA-RIITTA TASKINEN

Chair:
  • M. John Chapman, France
  • Henry Ginsberg, USA
Disturbances in hepatic and lipoprotein metabolism is the hallmark of atherogenic dyslipidaemia
Marja-Riitta Taskinen, Helsinki, Finland

Tuesday 08 May 09:00-11:00

STRATEGIES TO DETECT AND TREAT ATHEROSCLEROSIS

Chair:
  • Alberico L. Catapano, Italy
  • Chris Packard, UK
Lessons from genetics: risk-score and novel candidates
Brian A. Ference, Cambridge, United Kingdom
Atherothrombosis; from pathogenesis to treatment
Steffen Massberg, Munich, Germany
Novel therapeutic approaches using antisense inhibition
Joseph L. Witztum, La Jolla, USA
Strategies to treat vulnerable plaques
David Erlinge, Lund, Sweden